Barclays Maintains an 'Overweight' on Teva Pharma (TEVA); Detailed Laquinimod Results Support Our Positive View
Go back to Barclays Maintains an 'Overweight' on Teva Pharma (TEVA); Detailed Laquinimod Results Support Our Positive View| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 37.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.47 | 52 Week High | $66.55 | |||
| Open | $37.47 | 52 Week Low | $37.82 | |||
| Day High | $37.47 | P/E | N/A | |||
| Day Low | $37.47 | EPS | $0.00 | |||
| Volume | 3,300 | |||||
